Although data from twin studies showed that the genetic contribution to PCa risk is approximately 40% [6, 7], only a few mutations in genes such as BRCA1, BRCA2, and HOXB13 definitely account for a small proportion of cases of hereditary prostate cancer [8–10]. This evidence concerns the gene HOXB13 and prostate carcinoma.